MMRGlobal and Cerner Announce Patent Agreement
LOS ANGELES, CA--(Marketwired - Mar 12, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR") today announced an agreement with Cerner
Corporation relating to MMR's MyMedicalRecords, Inc. Personal
Health Record patent portfolio, including U.S. Patent Nos.
8,117,045; 8,117,646; 8,121,855; 8,301,466; 8,321,240; 8,352,287;
8,352,288; 8,498,883, 8,626,532 and 8,645,161. The confidential
agreement includes other terms and conditions related to an ongoing
business relationship between the parties.
MMRGlobal CEO, Robert H. Lorsch stated, "We're pleased to
announce this Patent Agreement with Cerner which represents a
unique opportunity for Cerner to benefit from MMR's patented
intellectual property. MMR is especially proud to have entered
into this agreement with an organization that collectively provides
solutions to more than 14,000 facilities worldwide including more
than 3,000 hospitals and 2,900 physician practices."
MMR's U.S. patent portfolio includes more than 250 issued claims
and additional applications and continuation applications. The
patents involve inventions pertaining to Personal Health Records,
Patient Portals and other Electronic Health Record systems. In
addition to its U.S. patents, the Company also has patents issued,
pending and/or applied for in 11 other countries or regional
authorities of commercial interest including Australia, Singapore,
New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea,
Israel and Europe.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access
their medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using
a variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records
and sharing them with patients through an integrated patient
portal. Through its merger with Favrille, Inc. in January 2009, the
Company acquired intellectual property biotech assets that include
anti-CD20 antibodies and data and samples from its FavId™/Specifid™
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit
www.mmrglobal.com. View demos and video tutorials of the Company's
products and services at www.mmrtheater.com.
Forward-Looking Statements All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance.
Such statements are necessarily based on assumptions and estimates
and are subject to various risks and uncertainties, including those
relating to the possible invalidity of the underlying assumptions
and estimates and possible changes or developments in economic,
business, industry, market, legal and regulatory circumstances and
conditions and actions taken or omitted to be taken by third
parties, including customers, suppliers, business partners,
potential licensees, competitors and legislative, judicial and
other governmental authorities and officials. Factors that could
cause or contribute to such differences include, but are not
limited to: unexpected outcomes with respect to intellectual
property enforcement actions, claims of intellectual property
infringement and general intellectual property litigation; our
ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business
prospects, results of operations or financial condition; risks
related to the current uncertainty and instability in financial and
lending markets, including global economic uncertainties; the
timing and volume of sales and installations; the length of sales
cycles and the installation process; the market's acceptance of new
product and service introductions; competitive product offerings
and promotions; changes in government laws and regulations
including the 2009 HITECH Act and changes in Meaningful Use and the
2010 Affordable Care Act; future changes in tax legislation and
initiatives in the healthcare industry; undetected errors in our
products; the possibility of interruption at our data centers;
risks related to third party vendors; risks related to obtaining
and integrating third-party licensed technology; risks related to a
security breach by third parties; risks associated with recruitment
and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in MMR's
filings with the Securities and Exchange Commission. MMR is
providing this information as of the date of this release and,
except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in
this release as a result of new information, future events or
otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033